アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/12 | 2,152 | 2,152 | 2,110.5 | 2,129 | +27 | +1.3% | 6,577,700 |
2023/05/11 | 2,095 | 2,105 | 2,088 | 2,102 | +6.5 | +0.3% | 3,977,800 |
2023/05/10 | 2,095 | 2,102 | 2,086 | 2,095.5 | -13.5 | -0.6% | 5,466,600 |
2023/05/09 | 2,073.5 | 2,113.5 | 2,072 | 2,109 | +40 | +1.9% | 4,698,100 |
2023/05/08 | 2,087 | 2,088 | 2,057.5 | 2,069 | -11 | -0.5% | 6,241,000 |
2023/05/02 | 2,100 | 2,118 | 2,074.5 | 2,080 | -13 | -0.6% | 6,678,900 |
2023/05/01 | 2,030 | 2,098.5 | 2,030 | 2,093 | +45 | +2.2% | 6,810,000 |
2023/04/28 | 2,040 | 2,052.5 | 2,025 | 2,048 | +67 | +3.4% | 8,316,200 |
2023/04/27 | 1,980 | 1,987 | 1,972 | 1,981 | -8.5 | -0.4% | 5,682,600 |
2023/04/26 | 2,010 | 2,017 | 1,978.5 | 1,989.5 | -27 | -1.3% | 3,980,200 |
2023/04/25 | 2,002.5 | 2,024 | 1,997 | 2,016.5 | +4.5 | +0.2% | 3,768,700 |
2023/04/24 | 2,011 | 2,014.5 | 2,004.5 | 2,012 | +15.5 | +0.8% | 2,531,000 |
2023/04/21 | 1,989.5 | 2,002 | 1,983 | 1,996.5 | -3.5 | -0.2% | 3,128,200 |
2023/04/20 | 2,008.5 | 2,008.5 | 1,991 | 2,000 | -10.5 | -0.5% | 3,577,400 |
2023/04/19 | 2,007 | 2,017.5 | 2,001 | 2,010.5 | -4 | -0.2% | 3,814,800 |
2023/04/18 | 1,999.5 | 2,019 | 1,994 | 2,014.5 | +15 | +0.8% | 4,124,900 |
2023/04/17 | 1,980 | 2,003.5 | 1,975 | 1,999.5 | +51.5 | +2.6% | 6,595,400 |
2023/04/14 | 1,946 | 1,950 | 1,929 | 1,948 | +7 | +0.4% | 5,817,000 |
2023/04/13 | 1,931 | 1,946 | 1,926 | 1,941 | +16 | +0.8% | 4,523,500 |
2023/04/12 | 1,910 | 1,930 | 1,907.5 | 1,925 | ±0 | ±0% | 5,032,400 |
2023/04/11 | 1,924.5 | 1,939.5 | 1,918 | 1,925 | +6.5 | +0.3% | 3,841,800 |
2023/04/10 | 1,911 | 1,924.5 | 1,903 | 1,918.5 | +19 | +1% | 3,493,900 |
2023/04/07 | 1,915 | 1,917 | 1,895 | 1,899.5 | -26 | -1.4% | 3,178,100 |
2023/04/06 | 1,903 | 1,928.5 | 1,895 | 1,925.5 | +31.5 | +1.7% | 5,437,400 |
2023/04/05 | 1,922 | 1,924 | 1,887 | 1,894 | -28 | -1.5% | 4,506,300 |
2023/04/04 | 1,894 | 1,923.5 | 1,886 | 1,922 | +43.5 | +2.3% | 6,245,000 |
2023/04/03 | 1,885 | 1,888 | 1,877 | 1,878.5 | -4.5 | -0.2% | 4,159,000 |
2023/03/31 | 1,887 | 1,891 | 1,878 | 1,883 | +5 | +0.3% | 7,095,000 |
2023/03/30 | 1,876 | 1,882 | 1,865.5 | 1,878 | -29.5 | -1.5% | 4,669,500 |
2023/03/29 | 1,882.5 | 1,908.5 | 1,872 | 1,907.5 | +15.5 | +0.8% | 5,944,500 |
2023/03/28 | 1,892.5 | 1,902 | 1,877.5 | 1,892 | +25.5 | +1.4% | 4,460,100 |
2023/03/27 | 1,850 | 1,872.5 | 1,847.5 | 1,866.5 | +21.5 | +1.2% | 3,539,200 |
2023/03/24 | 1,849 | 1,849 | 1,835 | 1,845 | +2 | +0.1% | 3,944,500 |
2023/03/23 | 1,854 | 1,854.5 | 1,826 | 1,843 | -23 | -1.2% | 4,885,700 |
2023/03/22 | 1,847 | 1,871.5 | 1,840.5 | 1,866 | +33.5 | +1.8% | 6,902,900 |
2023/03/20 | 1,851 | 1,856.5 | 1,831 | 1,832.5 | -18 | -1% | 5,130,500 |
2023/03/17 | 1,836.5 | 1,856 | 1,836 | 1,850.5 | +3 | +0.2% | 10,311,900 |
2023/03/16 | 1,837.5 | 1,852 | 1,823.5 | 1,847.5 | -24.5 | -1.3% | 5,949,300 |
2023/03/15 | 1,875.5 | 1,882 | 1,863.5 | 1,872 | -7.5 | -0.4% | 8,029,900 |
2023/03/14 | 1,876 | 1,896 | 1,862 | 1,879.5 | -6.5 | -0.3% | 8,712,300 |
2023/03/13 | 1,891 | 1,899.5 | 1,876 | 1,886 | -19 | -1% | 6,375,100 |
2023/03/10 | 1,925 | 1,927 | 1,905 | 1,905 | -30.5 | -1.6% | 9,228,600 |
2023/03/09 | 1,940 | 1,940.5 | 1,929 | 1,935.5 | +5.5 | +0.3% | 4,582,600 |
2023/03/08 | 1,923 | 1,933 | 1,915.5 | 1,930 | +12.5 | +0.7% | 4,966,800 |
2023/03/07 | 1,903 | 1,925.5 | 1,903 | 1,917.5 | +9 | +0.5% | 6,671,700 |
2023/03/06 | 1,920 | 1,925.5 | 1,903 | 1,908.5 | -3.5 | -0.2% | 6,433,300 |
2023/03/03 | 1,903.5 | 1,917 | 1,896 | 1,912 | +8.5 | +0.4% | 8,975,600 |
2023/03/02 | 1,903.5 | 1,914.5 | 1,897.5 | 1,903.5 | -7.5 | -0.4% | 7,613,600 |
2023/03/01 | 1,912.5 | 1,919 | 1,904.5 | 1,911 | -8 | -0.4% | 5,441,100 |
2023/02/28 | 1,923 | 1,938 | 1,915 | 1,919 | -4 | -0.2% | 8,016,900 |
251~
300
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,100円 | +2.9% | +72.2% | 4.90% | 90.32倍 | 1.70倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 416,500円 | +2.0% | +4.2% | 4.71% | 112.66倍 | 0.90倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 650,500円 | +6.0% | +131.3% | 1.84% | 14.13倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 714,400円 | +4.6% | +0.9% | 2.38% | 12.42倍 | 1.64倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 665,500円 | +1.7% | -2.9% | 2.40% | 44.42倍 | 2.18倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム